Cargando…
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
The pathogenesis of ocular adnexal marginal zone lymphomas of mucosa-associated lymphatic tissue-type (OAML) is still poorly understood. We analyzed 63 cases of such lymphomas for non-synonymous mutations in 24 candidate genes by amplicon sequencing. We validated frequent mutations in the NF-κB regu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308752/ https://www.ncbi.nlm.nih.gov/pubmed/27566587 http://dx.doi.org/10.18632/oncotarget.11548 |
_version_ | 1782507593023881216 |
---|---|
author | Johansson, Patricia Klein-Hitpass, Ludger Grabellus, Florian Arnold, Georg Klapper, Wolfram Pförtner, Roman Dührsen, Ulrich Eckstein, Anja Dürig, Jan Küppers, Ralf |
author_facet | Johansson, Patricia Klein-Hitpass, Ludger Grabellus, Florian Arnold, Georg Klapper, Wolfram Pförtner, Roman Dührsen, Ulrich Eckstein, Anja Dürig, Jan Küppers, Ralf |
author_sort | Johansson, Patricia |
collection | PubMed |
description | The pathogenesis of ocular adnexal marginal zone lymphomas of mucosa-associated lymphatic tissue-type (OAML) is still poorly understood. We analyzed 63 cases of such lymphomas for non-synonymous mutations in 24 candidate genes by amplicon sequencing. We validated frequent mutations in the NF-κB regulators MYD88, TNFAIP3 and TNIP1 in OAML, but also identified recurrent mutations in several additional components of the NF-κB pathway, including BCL10 and NFKBIA. Overall, 60% of cases had mutations in at least one component of NF-κB signaling, pointing to a central role of its genetic deregulation in OAML pathogenesis. Mutations in NOTCH1 and NOTCH2 were each found in 8% of cases, indicating a pathogenetic function of these factors in OAML. KMT2D was identified as the first epigenetic regulator with mutations in OAML, being mutated in 22% of cases. Mutations in MYD88 were associated with an inferior disease-free survival. Overall, we identified here highly recurrent genetic lesions in components of the NF-κB pathway, of NOTCH1 and NOTCH2 as well as KMT2D in OAML and thereby provide major novel insights into the pathogenesis of this B cell malignancy. |
format | Online Article Text |
id | pubmed-5308752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53087522017-03-09 Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas Johansson, Patricia Klein-Hitpass, Ludger Grabellus, Florian Arnold, Georg Klapper, Wolfram Pförtner, Roman Dührsen, Ulrich Eckstein, Anja Dürig, Jan Küppers, Ralf Oncotarget Research Paper The pathogenesis of ocular adnexal marginal zone lymphomas of mucosa-associated lymphatic tissue-type (OAML) is still poorly understood. We analyzed 63 cases of such lymphomas for non-synonymous mutations in 24 candidate genes by amplicon sequencing. We validated frequent mutations in the NF-κB regulators MYD88, TNFAIP3 and TNIP1 in OAML, but also identified recurrent mutations in several additional components of the NF-κB pathway, including BCL10 and NFKBIA. Overall, 60% of cases had mutations in at least one component of NF-κB signaling, pointing to a central role of its genetic deregulation in OAML pathogenesis. Mutations in NOTCH1 and NOTCH2 were each found in 8% of cases, indicating a pathogenetic function of these factors in OAML. KMT2D was identified as the first epigenetic regulator with mutations in OAML, being mutated in 22% of cases. Mutations in MYD88 were associated with an inferior disease-free survival. Overall, we identified here highly recurrent genetic lesions in components of the NF-κB pathway, of NOTCH1 and NOTCH2 as well as KMT2D in OAML and thereby provide major novel insights into the pathogenesis of this B cell malignancy. Impact Journals LLC 2016-08-23 /pmc/articles/PMC5308752/ /pubmed/27566587 http://dx.doi.org/10.18632/oncotarget.11548 Text en Copyright: © 2016 Johansson et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Johansson, Patricia Klein-Hitpass, Ludger Grabellus, Florian Arnold, Georg Klapper, Wolfram Pförtner, Roman Dührsen, Ulrich Eckstein, Anja Dürig, Jan Küppers, Ralf Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas |
title | Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas |
title_full | Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas |
title_fullStr | Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas |
title_full_unstemmed | Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas |
title_short | Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas |
title_sort | recurrent mutations in nf-κb pathway components, kmt2d, and notch1/2 in ocular adnexal malt-type marginal zone lymphomas |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308752/ https://www.ncbi.nlm.nih.gov/pubmed/27566587 http://dx.doi.org/10.18632/oncotarget.11548 |
work_keys_str_mv | AT johanssonpatricia recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas AT kleinhitpassludger recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas AT grabellusflorian recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas AT arnoldgeorg recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas AT klapperwolfram recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas AT pfortnerroman recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas AT duhrsenulrich recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas AT ecksteinanja recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas AT durigjan recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas AT kuppersralf recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas |